Overview
KPC825 is a strain of Klebsiella pneumoniae that produces Klebsiella pneumoniae carbapenemase (KPC), an enzyme that confers resistance to carbapenem antibiotics. Carbapenems are often considered last-resort antibiotics for treating severe bacterial infections. The emergence of KPC-producing strains like KPC825 has become a major public health concern due to limited treatment options. This strain is particularly problematic in hospital settings, where it can spread rapidly among patients, especially those with compromised immune systems. The World Health Organization (WHO) has classified carbapenem-resistant Enterobacteriaceae (CRE), including KPC-producing strains, as a critical priority for research and development of new antibiotics.
Key Features
KPC825 exhibits multidrug resistance, primarily due to the production of KPC enzymes that hydrolyze carbapenems and other beta-lactam antibiotics. This resistance mechanism is often encoded on plasmids, which can be transferred between bacterial species, facilitating the spread of resistance genes. In addition to carbapenem resistance, KPC825 may also show resistance to other antibiotic classes, such as fluoroquinolones and aminoglycosides, further limiting treatment options. The strain's ability to colonize patients asymptomatically complicates infection control efforts, as carriers can unknowingly spread the bacteria in healthcare environments.
Application Areas
KPC825 is primarily studied in clinical microbiology and antibiotic resistance research. Understanding its resistance mechanisms and transmission patterns is crucial for developing effective infection control strategies and novel antimicrobial therapies. In clinical settings, rapid detection of KPC-producing strains is essential for implementing appropriate isolation measures and guiding treatment decisions. Research on KPC825 also contributes to the development of diagnostic tests and surveillance systems for monitoring the spread of carbapenem-resistant bacteria.
Precautions
Handling KPC825 requires strict adherence to biosafety protocols, particularly in laboratory and healthcare settings. Proper personal protective equipment (PPE) and containment measures are necessary to prevent accidental exposure or transmission. Infection prevention strategies for KPC825 include active surveillance screening, contact precautions for colonized or infected patients, and thorough environmental cleaning. Antibiotic stewardship programs are critical to reducing the selective pressure that drives the emergence and spread of resistant strains like KPC825.
B2B Procurement Guide
For research institutions or diagnostic laboratories requiring KPC825 strains, it is essential to source from reputable culture collections that provide fully characterized and authenticated samples. Verify that the supplier complies with all relevant regulations for shipping and handling pathogenic microorganisms. Consider the strain's specific resistance profile and genotype when selecting KPC825 for research purposes. Ensure your facility has the appropriate biosafety level (BSL) containment and expertise to work with this pathogen safely. Documentation of source, passage history, and antimicrobial resistance patterns should be provided by the supplier.
Related Manufacturers
- 主营：发光二极管、UVLED、光耦、KPC825、传感器、红外发射接收管、数码管、厚声、三星、长电、村田、敦南二极管